Skip to main navigation Skip to search Skip to main content

Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer

  • Daniel C. Danila
  • , Michael J. Morris
  • , Johann S. De Bono
  • , Charles J. Ryan
  • , Samuel R. Denmeade
  • , Matthew R. Smith
  • , Mary Ellen Taplin
  • , Glenn J. Bubley
  • , Thian Kheoh
  • , Christopher Haqq
  • , Arturo Molina
  • , Aseem Anand
  • , Michael Koscuiszka
  • , Steve M. Larson
  • , Lawrence H. Schwartz
  • , Martin Fleisher
  • , Howard I. Scher

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science